BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND PR, PGR, progesterone receptor AND Clinical Outcome
10 results:

  • 1. clinical characteristics and prognosis of primary small cell carcinoma of the breast: a propensity score-matched, population-based study.
    Yin L; Yin AH; Pu CC
    BMJ Open; 2023 Dec; 13(12):e073841. PubMed ID: 38097248
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Positive
    Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
    Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nuclear hormone receptors in demyelinating diseases.
    Zorrilla Veloz RI; McKenzie T; Palacios BE; Hu J
    J Neuroendocrinol; 2022 Jul; 34(7):e13171. PubMed ID: 35734821
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. clinical prognostic evaluation of immunocytes in different molecular subtypes of breast cancer.
    Zenan H; Zixiong L; Zhicheng Y; Mei H; Xiongbin Y; Tiantian W; Min D; Renbin L; Changchang J
    J Cell Physiol; 2019 Nov; 234(11):20584-20602. PubMed ID: 31016756
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The role of hepatic trans-arterial chemoembolization in metastatic medullary thyroid carcinoma: a specialist center experience and review of the literature.
    Grozinsky-Glasberg S; Bloom AI; Lev-Cohain N; Klimov A; Besiso H; Gross DJ
    Eur J Endocrinol; 2017 Apr; 176(4):463-470. PubMed ID: 28100632
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features.
    Messuti I; Corvisieri S; Bardesono F; Rapa I; Giorcelli J; Pellerito R; Volante M; Orlandi F
    Eur J Endocrinol; 2014 May; 170(5):659-66. PubMed ID: 24510913
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas.
    Müssig K; Wehrmann T; Dittmann H; Wehrmann M; Ueberberg B; Schulz S; Bares R; Petersenn S
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):139-45. PubMed ID: 22248072
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Expression of estrogen receptor, progesterone receptor, and vascular endothelial growth factor-A in thyroid cancer.
    Kansakar E; Chang YJ; Mehrabi M; Mittal V
    Am Surg; 2009 Sep; 75(9):785-9; discussion 789. PubMed ID: 19774949
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prostate cancer with small-cell morphology: an immunophenotypic subdivision.
    Petraki C; Vaslamatzis M; Petraki K; Revelos K; Alevizopoulos N; Papanastasiou P; Gregorakis A
    Scand J Urol Nephrol; 2005; 39(6):455-63. PubMed ID: 16303720
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Estradiol modulation of plasminogen activator production in organ cultures of human breast carcinomas: correlation with clinical outcome of anti-estrogen therapy.
    Mira-y-Lopez R; Osborne MP; DePalo AJ; Ossowski L
    Int J Cancer; 1991 Apr; 47(6):827-32. PubMed ID: 1901298
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.